A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The goal of the proposed pilot study is to determine whether glucose control can be improved with Bydureon treatment in patients with type I diabetes (T1D)
Epistemonikos ID: 050194fb3f6ac4e3f11f6853a61e5a29be9dffa6
First added on: May 11, 2024